College of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Rd, Nanjing, 210023, P. R. China.
College of Pharmacy, Anhui University of Chinese Medicine, Anhui, 230012, P. R. China.
Chem Biodivers. 2022 Oct;19(10):e202200361. doi: 10.1002/cbdv.202200361. Epub 2022 Sep 16.
Curcumae Radix (CW) is traditionally used to treat dysmenorrhea caused by uterine spasm. However, the changes of its composition and anti-uterine spasms during vinegar processing and the mechanism in treating dysmenorrhea are not clear.
To elucidate the changes of anti-uterine spasm and its substance basis, and the mechanism of treating dysmenorrhea before and after vinegar processing.
The uterine spasm contraction model was established, and the uterine activity and its inhibition rate were calculated to evaluate the differences. The main chemical constituents of CW were quickly analyzed by UPLC-Q-TOF-MS/MS technology, and the differences between them were explored by multivariate statistical analysis. Then, the regulatory network of "active ingredients-core targets-signal pathways" related to dysmenorrhea was constructed by using network pharmacology, and the combination between differential active components and targets was verified by molecular docking.
CW extract relaxed the isolated uterine by reducing the contractile tension, amplitude, and frequency. Compared with CW, the inhibitory effect of vinegar products was stronger, and the inhibition rate was 70.08 %. 39 compounds were identified from CW and 13 differential components were screened out (p<0.05). Network pharmacology screened 11 active components and 32 potential targets, involving 10 key pathways related to dysmenorrhea. The results of molecular docking showed that these differentially active components had good binding activity to target.
It was preliminarily revealed that CW could treat dysmenorrhea mainly through the regulation of inflammatory reaction, relaxing smooth muscle and endocrine by curcumenone, 13-hydroxygermacrone, (+)-cuparene, caryophyllene oxide, zederone, and isocurcumenol.
莪术通常用于治疗子宫痉挛引起的痛经。然而,醋制前后其成分变化和抗子宫痉挛作用以及治疗痛经的机制尚不清楚。
阐明醋制前后抗子宫痉挛作用及其物质基础,治疗痛经的机制。
建立子宫痉挛收缩模型,计算子宫活动及其抑制率,评价差异。采用 UPLC-Q-TOF-MS/MS 技术快速分析莪术的主要化学成分,并通过多元统计分析探讨其差异。然后,通过网络药理学构建与痛经相关的“活性成分-核心靶点-信号通路”调控网络,并通过分子对接验证差异活性成分与靶点的结合。
莪术提取物通过降低收缩张力、幅度和频率来松弛分离的子宫。与莪术相比,醋制品的抑制作用更强,抑制率为 70.08%。从莪术中鉴定出 39 种化合物,筛选出 13 种差异成分(p<0.05)。网络药理学筛选出 11 种活性成分和 32 个潜在靶点,涉及 10 条与痛经相关的关键途径。分子对接结果表明,这些差异活性成分与靶点具有良好的结合活性。
初步揭示莪术主要通过莪术酮、13-羟基莪术二酮、(+)-姜烯、石竹烯氧化物、柠檬醛、异莪术醇等调节炎症反应、松弛平滑肌和内分泌来治疗痛经。